| Literature DB >> 29755782 |
Andreas Minh Luu1, Torsten Herzog1, Philipp Hoehn1, Anke Reinacher-Schick2, Johanna Munding3, Waldemar Uhl1, Chris Braumann1.
Abstract
Pancreatic cancer (PC) is a lethal disease with a poor prognosis. It is typically asymptomatic and therefore most often diagnosed at an advanced stage. A primary unresectable PC can become resectable in case of tumor regression turning palliative into neoadjuvant therapy. We present a 67-year old female patient who was diagnosed with a locally advanced adenocarcinoma of the pancreatic head. After receiving palliative intended chemotherapy with the FOLFIRINOX regimen, staging computed tomography revealed local resectability of the pancreatic head tumor. The patient underwent an uneventful total pancreatectomy. Pathohistological investigation revealed a pathologic complete response (pCR). pCR after FOLFIRINOX treatment in primary unresectable PC is extremely rare. It might enable surgical resection and can increase the survival rate.Entities:
Keywords: FOLFIRINOX; Pathologic complete response (pCR); pancreatic cancer (PC); ypT0
Year: 2018 PMID: 29755782 PMCID: PMC5934161 DOI: 10.21037/jgo.2018.01.07
Source DB: PubMed Journal: J Gastrointest Oncol ISSN: 2078-6891